Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C22H28ClFO4 |
Molecular Weight | 410.907 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 9 / 9 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]3(Cl)[C@@]2([H])C[C@H](F)C4=CC(=O)C=C[C@]34C
InChI
InChIKey=YMTMADLUXIRMGX-RFPWEZLHSA-N
InChI=1S/C22H28ClFO4/c1-11-6-13-14-8-16(24)15-7-12(26)4-5-21(15,3)22(14,23)18(28)9-20(13,2)19(11)17(27)10-25/h4-5,7,11,13-14,16,18-19,25,28H,6,8-10H2,1-3H3/t11-,13+,14+,16+,18+,19-,20+,21+,22+/m1/s1
Molecular Formula | C22H28ClFO4 |
Molecular Weight | 410.907 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 9 / 9 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/22791998Curator's Comment: https://www.ncbi.nlm.nih.gov/pubmed/22798972
Sources: https://www.ncbi.nlm.nih.gov/pubmed/22791998
Curator's Comment: https://www.ncbi.nlm.nih.gov/pubmed/22798972
Clocortolone (used in form of pivalate prodrug) is a topical glucocorticoid that was approved by FDA for the treatment of corticosteroid-responsive skin disorders. The drug exerts its anti-inflammatory action by binding to glucocorticoid receptor which results in regulation of the expression of proinflammatory cytokines and further antiproliferative, immunosuppressive, and initial vasoconstrictive effects.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P04150 Gene ID: 2908.0 Gene Symbol: NR3C1 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/22798972 |
|||
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | CLODERM Approved UseTopical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Launch Date1977 |
PubMed
Title | Date | PubMed |
---|---|---|
Clocortolone, a new topical steroid in dermatoses. | 1973 Mar 24 |
|
Safety and efficacy of clocortolone pivalate 0.1 percent cream in the treatment of atopic dermatitis, contact dermatitis, and seborrheic dermatitis. | 1981 Jun |
|
Adherence to clocortolone pivalate cream 0.1% in a pediatric population with atopic dermatitis. | 2008 May |
|
Clocortolone pivalate: a topical corticosteroid with a unique structure. | 2013 Feb |
|
The role of a midpotency topical corticosteroid and the clinical relevance of formulation characteristics in the management of commonly encountered eczematous and inflammatory dermatoses in adults and children: focus on the pharmacologic properties of clocortolone pivalate 0.1% cream. | 2013 Feb |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:03:51 GMT 2023
by
admin
on
Fri Dec 15 15:03:51 GMT 2023
|
Record UNII |
N8ZUB7XE0H
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
D07AB21
Created by
admin on Fri Dec 15 15:03:51 GMT 2023 , Edited by admin on Fri Dec 15 15:03:51 GMT 2023
|
||
|
NDF-RT |
N0000175450
Created by
admin on Fri Dec 15 15:03:51 GMT 2023 , Edited by admin on Fri Dec 15 15:03:51 GMT 2023
|
||
|
NDF-RT |
N0000175576
Created by
admin on Fri Dec 15 15:03:51 GMT 2023 , Edited by admin on Fri Dec 15 15:03:51 GMT 2023
|
||
|
WHO-VATC |
QD07AB21
Created by
admin on Fri Dec 15 15:03:51 GMT 2023 , Edited by admin on Fri Dec 15 15:03:51 GMT 2023
|
||
|
NCI_THESAURUS |
C521
Created by
admin on Fri Dec 15 15:03:51 GMT 2023 , Edited by admin on Fri Dec 15 15:03:51 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CLOCORTOLONE
Created by
admin on Fri Dec 15 15:03:51 GMT 2023 , Edited by admin on Fri Dec 15 15:03:51 GMT 2023
|
PRIMARY | |||
|
100000084286
Created by
admin on Fri Dec 15 15:03:51 GMT 2023 , Edited by admin on Fri Dec 15 15:03:51 GMT 2023
|
PRIMARY | |||
|
N8ZUB7XE0H
Created by
admin on Fri Dec 15 15:03:51 GMT 2023 , Edited by admin on Fri Dec 15 15:03:51 GMT 2023
|
PRIMARY | |||
|
N8ZUB7XE0H
Created by
admin on Fri Dec 15 15:03:51 GMT 2023 , Edited by admin on Fri Dec 15 15:03:51 GMT 2023
|
PRIMARY | |||
|
C61684
Created by
admin on Fri Dec 15 15:03:51 GMT 2023 , Edited by admin on Fri Dec 15 15:03:51 GMT 2023
|
PRIMARY | |||
|
DB00838
Created by
admin on Fri Dec 15 15:03:51 GMT 2023 , Edited by admin on Fri Dec 15 15:03:51 GMT 2023
|
PRIMARY | |||
|
21249
Created by
admin on Fri Dec 15 15:03:51 GMT 2023 , Edited by admin on Fri Dec 15 15:03:51 GMT 2023
|
PRIMARY | RxNorm | ||
|
CHEMBL2106011
Created by
admin on Fri Dec 15 15:03:51 GMT 2023 , Edited by admin on Fri Dec 15 15:03:51 GMT 2023
|
PRIMARY | |||
|
225-406-7
Created by
admin on Fri Dec 15 15:03:51 GMT 2023 , Edited by admin on Fri Dec 15 15:03:51 GMT 2023
|
PRIMARY | |||
|
DTXSID901333489
Created by
admin on Fri Dec 15 15:03:51 GMT 2023 , Edited by admin on Fri Dec 15 15:03:51 GMT 2023
|
PRIMARY | |||
|
59582
Created by
admin on Fri Dec 15 15:03:51 GMT 2023 , Edited by admin on Fri Dec 15 15:03:51 GMT 2023
|
PRIMARY | |||
|
1138493
Created by
admin on Fri Dec 15 15:03:51 GMT 2023 , Edited by admin on Fri Dec 15 15:03:51 GMT 2023
|
PRIMARY | |||
|
2113
Created by
admin on Fri Dec 15 15:03:51 GMT 2023 , Edited by admin on Fri Dec 15 15:03:51 GMT 2023
|
PRIMARY | |||
|
C004686
Created by
admin on Fri Dec 15 15:03:51 GMT 2023 , Edited by admin on Fri Dec 15 15:03:51 GMT 2023
|
PRIMARY | |||
|
SUB06686MIG
Created by
admin on Fri Dec 15 15:03:51 GMT 2023 , Edited by admin on Fri Dec 15 15:03:51 GMT 2023
|
PRIMARY | |||
|
m3633
Created by
admin on Fri Dec 15 15:03:51 GMT 2023 , Edited by admin on Fri Dec 15 15:03:51 GMT 2023
|
PRIMARY | Merck Index | ||
|
5311052
Created by
admin on Fri Dec 15 15:03:51 GMT 2023 , Edited by admin on Fri Dec 15 15:03:51 GMT 2023
|
PRIMARY | |||
|
4828-27-7
Created by
admin on Fri Dec 15 15:03:51 GMT 2023 , Edited by admin on Fri Dec 15 15:03:51 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |